Arthur Taveras, Chief Scientific Officer: X4 Pharmaceuticals XFOR Sell · Filed 24/02/12

Trade details

Type: Insider sale
Amount: $794.87
Shares · price: 787 sh · $1.01 a share
Held after: 248,536 sh
Stock: X4 Pharmaceuticals XFOR
Person: Arthur TaverasChief Scientific Officer
Trade date: 24/02/12
Filed: 24/02/12
Days to filing: 0 days

Sold 0.3% of holdings

Share of holding sold: 0.3%

X4 Pharmaceuticals trades, last 26 weeks

What else happened in X4 Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/01/13~24/03/13

Arthur Taveras's recent trades

Arthur TaverasOfficer
Planned sale10b5-1 planX4 Pharmaceuticals
Planned sale10b5-1 plan
X4 Pharmaceuticals
XFOR
$12.9K
24,828 sh
$12.9K
Filed 25/01/24
Traded 25/01/24
Arthur TaverasChief Scientific Officer
SellX4 Pharmaceuticals
Sell
X4 Pharmaceuticals
XFOR
$43.1K
76,920 sh
$43.1K
Filed 24/10/08
Traded 24/10/07
Arthur TaverasChief Scientific Officer
SellX4 Pharmaceuticals
Sell
X4 Pharmaceuticals
XFOR
$12.5K
14,235 sh
$12.5K
Filed 24/03/11
Traded 24/03/11
Arthur TaverasChief Scientific Officer
Sell10b5-1 planX4 Pharmaceuticals
Sell10b5-1 plan
X4 Pharmaceuticals
XFOR
$49.4K
67,695 sh
$49.4K
Filed 23/11/03
Traded 23/11/01
Arthur TaverasChief Scientific Officer
SellX4 Pharmaceuticals
Sell
X4 Pharmaceuticals
XFOR
$14.1K
16,806 sh
$14.1K
Filed 23/03/13
Traded 23/03/10